Save 20% on Press Releases and More with NNW Prime! Click to View Details
MondayNov 09, 2020 9:45 am

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Unveil Adaptive Design for Berubicin Phase 2 Clinical Trial in Nov. 12 Webinar

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today announced its plans to issue a video update at 4:30 p.m. ET on Nov. 12, 2020, to discuss the clinical trial design for its upcoming Phase 2 U.S. trial for Berubicin. CNSP’s lead drug candidate – Berubicin – is proposed for the treatment of glioblastoma multiforme (“GBM”), an aggressive form of brain cancer, currently considered incurable. Robert LeBoyer, managing director of equity research at Ladenburg Thalmann & Co. Inc., will moderate the discussion.…

Continue Reading

FridayNov 06, 2020 12:24 pm

NetworkNewsBreaks – Microsoft Corporation (NASDAQ: MSFT) Featured in Analysis Report

Microsoft (NASDAQ: MSFT), an American multinational technology company with a mission to empower individuals and organizations, was featured in a recent analysis report that discussed soaring consumer demand for MSFT Xbox products. The report, written by LikeFolio Founder Andy Swan, reads, “In the meantime, another key segment caught our attention: gaming. Xbox Series X and Series S preorders began Sept. 22 and demand mentions soared. It was the largest purchase intent spike for the brand we've ever recorded. Tweets showed pre-order sellout in seconds. Consoles arrive Nov. 10. . . just in time for the holiday shopping. Xbox is only…

Continue Reading

FridayNov 06, 2020 12:02 pm

NetworkNewsBreaks – Lululemon Athletica Inc. (NASDAQ: LULU) Featured in Analysis Report

Lululemon (NASDAQ: LULU), a healthy lifestyle inspired athletic apparel company, was featured in a recent analysis report that discussed its consumer demand leading into the holiday season. The report, written by LikeFolio Founder Andy Swan, reads, “We won't lie, we were shocked to see athleisure-darling Lululemon launch a ‘We Made Too Much’ section on its website, full of markdowns for more than 480 products. But then we took a look at LikeFolio data, and it made much more sense. That shaded 20Q3 bar on the far right ends Nov. 1. . . and it's currently pacing -29% QoQ and -24%…

Continue Reading

FridayNov 06, 2020 11:41 am

NetworkNewsBreaks – Intel Corporation (NASDAQ: INTC) Featured in Analysis Report

Intel (NASDAQ: INTC), the world's largest and highest-valued semiconductor chip manufacturer, was featured in a recent analysis report that discussed its performance. The report, written by LikeFolio Founder Andy Swan, reads, “Last quarter, Intel beat revenue and EPS estimates but was dinged on weaker than expected guidance and a delayed timeline for its release of 7-nm chips. LikeFolio data shows consumer buzz is building for Intel's product suite, increasing 13% YoY in 20Q3 and holding volume into the current quarter. This tells us that Intel appears to be making moves in a positive direction from the consumer perspective. What this…

Continue Reading

FridayNov 06, 2020 11:17 am

NetworkNewsBreaks – CYBIN Inc. Completes Reverse Takeover Transaction

CYBIN (formerly Clarmin Explorations Inc.), a life sciences company initially focused on psychedelic pharmaceutical therapies, on Thursday announced it has completed its previously disclosed reverse takeover of Clarmin Explorations Inc. per the terms of an amalgamation agreement dated June 26, 2020, as amended on October 21, 2020. The agreement was among Cybin Corp., Clarmin and 2762898 Ontario Inc. (“SubCo”), a wholly-owned subsidiary of the company (the “reverse takeover”), in which the reverse takeover was completed by way of a “three-cornered” amalgamation pursuant to the provisions of the Business Corporations Act (Ontario). Through the reverse takeover, Cybin Corp. amalgamated with SubCo…

Continue Reading

FridayNov 06, 2020 10:21 am

NetworkNewsBreaks – Josemaria Resources Inc. (TSX: JOSE) (OTC: JOSMF) Files Technical Report for Argentina Copper-Gold Project

Josemaria Resources (TSX: JOSE) (OTC: JOSMF) on Thursday announced that it has filed a technical report prepared under National Instrument 43-101 Standards for Disclosure for Mineral Projects. The report is regarding the company's 100% owned Josemaria Copper-Gold Project, located in San Juan Province, Argentina. The technical report is being filed in support of the information contained in the company's news release dated October 19, 2020, entitled "Josemaria Resources Announces Positive Feasibility Study Showcasing a Conventional, Robust and Rapid Pay Back, Open Pit Copper-Gold Project," as well as in Josemaria's Material Change Report dated October 21, 2020. To view the full…

Continue Reading

FridayNov 06, 2020 9:17 am

NetworkNewsBreaks – Turning Point Therapeutics Inc. (NASDAQ: TPTX) Secures $460M in Underwritten Public Offering

Turning Point Therapeutics (NASDAQ: TPTX), a precision oncology company developing next-generation therapies that target genetic drivers of cancer, has closed an underwritten public offering of 5,287,357 shares of its common stock, including 689,655 additional shares per the full exercise of the over-allotment option granted to the underwriters. According to the update, Turning Point Therapeutics secured approximately $460 million in gross proceeds, with each of the shares sold at the public offering price of $87.00. Roth Capital Partners acted as co-manager for the offering. For more information, visit the company’s website at: www.TPTherapeutics.com About Turning Point Therapeutics Turning Point is a…

Continue Reading

ThursdayNov 05, 2020 1:15 pm

NetworkNewsBreaks – GoldHaven Resources Corp. (CSE: GOH) (OTCQB: ATUMF) Secures $2.449M in Over-Subscribed Non-Brokered Private Placement

GoldHaven Resources (CSE: GOH) (OTCQB: ATUMF), a Canada-based company engaged in the business of acquiring and exploring mineral resource properties, today announced that it has closed a final tranche of an over-subscribed non-brokered private placement (the "offering"). GoldHaven secured aggregate total proceeds of $2,449,500 through closing of two tranches, previously announced on Oct. 16, Oct. 29 and Nov. 4, 2020, which consisted of a total of 12,247,500 aggregate units, each sold at a price of $0.20. The company intends to use net proceeds to commence an exploration program on its Maricunga Gold Belt projects, as well as for general working…

Continue Reading

ThursdayNov 05, 2020 12:52 pm

NetworkNewsBreaks – Sugarmade Inc. (SGMD) Undertakes Marketing Analysis Ahead of Planned BudCars Expansion

Sugarmade (OTCQB: SGMD) today announced that, in anticipation of the planned expansion of the BudCars cannabis delivery service into new territories, it has undertaken an analysis of the efficacy of marketing spending relative to market size and population for the existing BudCars regional delivery footprint. According to the update, Sugarmade believes this may provide some insight into performance benchmarks and expectations related to the anticipated expansion into the North San Francisco Bay Area and the Wine Country counties, followed by Los Angeles. “We are very confident in the ROI associated with spending on BudCars marketing in connection with BudCars’ expansion,”…

Continue Reading

ThursdayNov 05, 2020 12:30 pm

NetworkNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Announces Board Appointment of Dr. Khalid Islam

Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage biopharmaceutical company developing products to improve survival and/or quality of life for patients with a high unmet medical need, today announced the appointment of Dr. Khalid Islam to its board of directors. Dr. Islam was the chairman and CEO of Gentium S.p.A. (a Nasdaq-listed company; 2009-2014) where he led its transition to a profitable company that subsequently sold for US$1 billion. In addition, he is currently an advisor to the venture group Kurma Biofund (Paris), the chairman of the board for Fennec Pharmaceuticals Inc. (NASDAQ: FENC), Gain Therapeutics Inc. and Minoryx Therapeutics SL, and…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000